Cargando…
Mettl5 mediated 18S rRNA N6-methyladenosine (m(6)A) modification controls stem cell fate determination and neural function
Ribosome RNA (rRNA) accounts for more than 80% of the cell's total RNA, while the physiological functions of rRNA modifications are poorly understood. Mutations of 18S rRNA m(6)A methyltransferase METTL5 cause intellectual disability, microcephaly, and facial dysmorphisms in patients, however,...
Autores principales: | Wang, Lu, Liang, Yu, Lin, Rongzhi, Xiong, Qiuchan, Yu, Peng, Ma, Jieyi, Cheng, Maosheng, Han, Hui, Wang, Xiaochen, Wang, Ganping, Liang, Fengyin, Pei, Zhong, Chen, Demeng, Yuan, Quan, Jiang, Yi-Zhou, Lin, Shuibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720661/ https://www.ncbi.nlm.nih.gov/pubmed/35005123 http://dx.doi.org/10.1016/j.gendis.2020.07.004 |
Ejemplares similares
-
METTL3-Mediated m(6)A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway
por: Liang, Yu, et al.
Publicado: (2021) -
METTL3-mediated m(6)A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
por: Han, Hui, et al.
Publicado: (2021) -
Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis
por: Wu, Yunshu, et al.
Publicado: (2018) -
N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity
por: Zheng, Siyi, et al.
Publicado: (2022) -
Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)